Plasma exchange and prednisone in Guillain-Barré syndrome: a controlled randomized trial. 1985

J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini

A controlled randomized trial of plasma exchange combined with prednisone was compared with supportive care alone in patients with Guillain-Barré syndrome (GBS). There was no significant improvement in the treated group over the controls. The sample size, albeit small (12 treated and 13 controls), had the power (95% chance) to detect a change of 2 British Medical Research Council grades of strength between the groups. The difference in our results and others that indicated a beneficial effect of plasma exchange may reflect an adverse effect of prednisone on recovery in GBS. Failure to find a benefit of plasma exchange in our patients also raises the possibility that GBS may be a heterogeneous disorder with humoral factors playing a role in some but not all patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011129 Polyradiculoneuropathy Diseases characterized by injury or dysfunction involving multiple peripheral nerves and nerve roots. The process may primarily affect myelin or nerve axons. Two of the more common demyelinating forms are acute inflammatory polyradiculopathy (GUILLAIN-BARRE SYNDROME) and POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING. Polyradiculoneuritis refers to inflammation of multiple peripheral nerves and spinal nerve roots. Autoimmune Demyelinating Disease, Peripheral,Demyelinating Autoimmune Disease, Peripheral,Demyelinating Disease, Peripheral Autoimmune,Peripheral Autoimmune Demyelinating Disease,Polyradiculoneuritis,Polyradiculoneuritides,Polyradiculoneuropathies
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
December 1994, Transfusion science,
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
April 1992, The New England journal of medicine,
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
January 1997, Lancet (London, England),
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
January 1990, Annales de medecine interne,
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
July 1985, Lancet (London, England),
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
January 1985, Journal of clinical apheresis,
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
September 1981, British medical journal (Clinical research ed.),
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
February 1984, Minerva medica,
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
January 1982, Nursing times,
J R Mendell, and J T Kissel, and M S Kennedy, and Z Sahenk, and H T Grinvalsky, and G L Pittman, and R S Kyler, and R I Roelofs, and J N Whitaker, and T E Bertorini
August 1989, Journal of the Royal Society of Medicine,
Copied contents to your clipboard!